Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic

Clin Infect Dis. 2014 Sep 15;59(6):834-41. doi: 10.1093/cid/ciu446. Epub 2014 Jun 13.

Abstract

Background: Trichomonas vaginalis (TV) is the most common nonviral sexually transmitted infection (STI) in the world. However, TV is not a reportable STI and, with the exception of HIV-positive women, there are no guidelines for screening in women or men. The objective of this study was to determine the added value of nucleic acid amplification tests (NAATs) for detection of TV in men and women at high risk for infection as well as correlates of infection.

Methods: This was a review of clinical and laboratory data of men and women presenting to the Jefferson County Department of Health Sexually Transmitted Diseases (STD) Clinic and receiving a TV NAAT.

Results: During 2012-2013, 6335 patients (3821 women and 2514 men) received a TV NAAT on endocervical, urethral, or urine specimens. Overall TV prevalence was 20.2%; 27.0% in women and 9.8% in men. Correlates of TV among men included age >40 years, African American race, and ≥5 polymorphonuclear cells per high-power field on urethral Gram stain. Age >40 years, African American race, leukorrhea on wet mount, elevated vaginal pH, positive whiff test, and concurrent gonococcal infection were positively associated with TV among women. TV NAAT detected approximately one-third more infections among women than wet mount alone.

Conclusions: TV prevalence among men and women was high in this study, suggesting that both groups should be routinely screened, including those aged >40 years. Improved detection of TV by routine implementation of NAATs should result in better control of this common, treatable STI.

Keywords: Trichomonas vaginalis; infectiousness; nucleic acid amplification test; sexually transmitted infection; wet mount.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiprotozoal Agents / therapeutic use
  • Female
  • Humans
  • Male
  • Metronidazole / therapeutic use
  • Middle Aged
  • Nucleic Acid Amplification Techniques*
  • Prevalence
  • Risk Factors
  • Sensitivity and Specificity
  • Sexually Transmitted Diseases / diagnosis*
  • Sexually Transmitted Diseases / drug therapy
  • Sexually Transmitted Diseases / epidemiology
  • Sexually Transmitted Diseases / parasitology*
  • Texas / epidemiology
  • Trichomonas Vaginitis / diagnosis*
  • Trichomonas Vaginitis / drug therapy
  • Trichomonas Vaginitis / epidemiology
  • Trichomonas Vaginitis / parasitology*
  • Trichomonas vaginalis / genetics*
  • Young Adult

Substances

  • Antiprotozoal Agents
  • Metronidazole